Global Heart
Clinical Characteristics and Outcomes of Elderly Patients Undergoing Primary Percutaneous Coronary Intervention: An Observational Cohort Study
Cohort study of 3,627 peoplePopulations
Papers on contrast-induced nephropathy
7 papers
Monday, January 6
Wednesday, October 16
Archivos Peruanos de Cardiologia y Cirugia Cardiovascular
Frailty and adverse outcomes in patients over 65 years old with acute coronary syndrome in a hospital cohort in Medellin, Colombia
Cohort study of 112 peopleAcute coronary syndrome
Tuesday, October 19
Oxidative Medicine and Cellular Longevity
Calorie Restriction Protects against Contrast-Induced Nephropathy via SIRT1/GPX4 Activation
Experiments in ratsDietary restriction
Monday, October 1
Internal Medicine
N-acetylcysteine for the prevention of contrast-induced nephropathy in the emergency department
Non-randomized trial in 209 peopleAcetylcysteine
Tuesday, September 1
The American Journal of Medicine
High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy
Meta-analysis of randomized trialsAcetylcysteine
Sunday, January 1
American Heart Journal
N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials
Meta-analysis of randomized trialsAcetylcysteine
Friday, October 1
American Heart Journal
N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up
Randomized trial in 180 peopleAcetylcysteine